Title : A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS.

Pub. Date : 2022 Jan

PMID : 35014217






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. UNII-4N6KQ7D685 mitogen-activated protein kinase kinase kinase 12 Homo sapiens
2 This first-in-human study investigated safety, tolerability, and pharmacokinetics (PK) of oral GDC-0134, a small-molecule DLK inhibitor. UNII-4N6KQ7D685 mitogen-activated protein kinase kinase kinase 12 Homo sapiens